Mount Sinai Heath System — New York, New York

Mount Sinai Heath System is a clinical research site located in New York, New York, United States 10019-1147.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai Heath System has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: ccRCC, RCC, Kidney Cancer.

Sponsors: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Heath System?

Mount Sinai Heath System has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Heath System conducted?

Mount Sinai Heath System has 1 clinical trials on record, with 1 currently active. Their work covers ccRCC, RCC, Kidney Cancer.

Is Mount Sinai Heath System accredited by Crixeo Health?

Mount Sinai Heath System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Heath System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.